Top Story

ACIP accepts proposed updates to typhoid vaccine statement

October 31, 2014

The Advisory Committee on Immunization Practices voted unanimously to accept proposed updates to the recommendations for typhoid vaccines.

There are no changes to the guidelines in terms of the populations recommended to receive the vaccine. The updated statement reflects changes in vaccine availability, new data on the epidemiology of typhoid and new data on vaccine safety and efficacy. The typhoid vaccine statement had not been updated since 1994.

In the Journals

Recorded outbreaks, unique diseases increased since 1980

October 31, 2014
The number of recorded outbreaks and unique diseases around the world seems to have increased since 1980 whereas per capita cases declined, according to recently…
Worth Building

Question your allocation to deal with recent stock market volatility

October 30, 2014
The summer stock market doldrums have morphed into a high octane volatile zig-zag. So I ask you – what is new? Haven’t we been here before? The trouble is…

Two Virginia hospitals receive first ID risk management certification

October 30, 2014
Sentara Leigh and Sentara Virginia Beach hospitals are the first two hospitals to receive the DNV Healthcare Centers for Excellence infection mitigation management…
More News Headlines »
CME
figure

Pediatric Perspectives on the Management of Diarrhea in Infants and Children - Monograph

This activity is supported by an educational grant from Lupin Pharmaceuticals, Inc.

An estimated 1.2 million cases of giardiasis and 750,000 cases of cryptosporidiosis occur in the United States…
More »
Meeting News Coverage Video
figure

Marshall discusses the safety, efficacy of a potential combination vaccine for infants

October 28, 2014
PHILADELPHIA — At IDWeek 2014, Gary S. Marshall, MD, chief of pediatric infectious diseases at the University of…
More »
CME CNE CPE Video
figure

Advances in Pharmacokinetic Enhancers in HIV Treatment: What You Need to Know to Optimize Outcomes

This activity is supported by an educational grant from Bristol-Myers Squibb.

Protease inhibitors (PIs) have played an instrumental role in decreasing mortality andmorbidity among HIV-infected…
More »